Lemierre syndrome is a rare but potentially life-threatening infectious disease characterized by septic thrombophlebitis of the internal jugular vein and metastatic foci of infection. The disease begins as an oropharyngeal infection, often caused by Fusobacterium necrophorum, which may progress to severe systemic infection with involvement of multiple organs. The clinical picture includes high fever, sore throat, cervical lymphadenopathy, and thrombus formation in the internal jugular vein, leading to septic emboli in the lungs and other organs.
History of the disease and interesting historical facts
The disease was first described by the French bacteriologist André Lemierre in 1936. In his work, he presented a detailed description of 20 cases with postmortem confirmation of the diagnosis. It is interesting to note that before the discovery of antibiotics, the mortality rate for this disease reached 90%. “In the pre-antibiotic era, Lemierre syndrome was one of the leading causes of death in young people,” notes a study in the Journal of Medical Microbiology (2018). Modern diagnostic and treatment methods have significantly improved the prognosis, but the disease remains difficult to diagnose due to its rarity.
Epidemiology
Despite its rarity, the incidence of Lemierre syndrome has shown an increasing trend, particularly among young adults and adolescents. According to a study published in Clinical Infectious Diseases, the incidence is about 1 case per million population per year. It is most common in the 15-30 age group, with men being affected slightly more often than women. In recent years, there has been an increase in the number of cases by 9-12% per year, which is associated with the wider use of diagnostic methods and increased awareness among physicians.
Genetic predisposition to this disease
Studies have shown the possible role of genetic predisposition in the development of Lemierre syndrome. Particular attention is paid to the polymorphism of the complement system genes, in particular C3 and C5. Mutations in the genes responsible for blood coagulation factors (FV Leiden, prothrombin G20210A) can also create a favorable background for the development of thrombosis. "Genetic analysis of patients with Lemierre syndrome revealed a significant increase in the frequency of mutations in the genes of the coagulation system," according to a study in the European Journal of Human Genetics (2021).
Risk factors for the development of this disease
- Immunodeficiency states, including HIV infection
- Chronic upper respiratory tract diseases
- Dental pathologies and inflammatory processes in the oral cavity
- Previous upper respiratory tract infections
- Neck injuries and surgeries in this area
- Smoking and alcohol abuse
Diagnosis of this disease
The main symptoms include high fever, sore throat, cervical lymphadenopathy and dyspnea. Laboratory studies reveal leukocytosis, elevated inflammatory markers. Radiological examinations:
- Ultrasound of the neck is the primary method for detecting thrombosis
- CT scan of the neck with contrast
- MRI for detailed visualization
- Angiography in complex cases
Differential diagnosis is carried out with other causes of sepsis and thrombosis.
Treatment
General treatment includes hospitalization in an intensive care unit. Pharmacological treatment:
- Antibacterial therapy (minimum 4 weeks)
- Anticoagulant therapy
- Symptomatic therapy
Surgical treatment is indicated in the presence of abscesses or ineffectiveness of conservative therapy.
List of drugs used to treat this disease
- Metronidazole
- Penicillin
- Ceftriaxone
- Clarithromycin
- Enoxaparin
- warfarin
Disease monitoring
Control stages include regular ultrasound of the neck every 2 weeks, coagulogram monitoring, clinical blood test. The prognosis with timely diagnosis is favorable, but serious complications may develop: septic shock, multiple organ failure, acute respiratory distress syndrome.
Age-related features of the disease
In children, the disease is more acute, often with a predominance of local manifestations. In adults, generalized forms with multiple metastatic foci are more often observed. In elderly patients, the course is more severe due to the presence of concomitant diseases and a reduced immune response.
Questions and Answers
- How quickly does Lemierre syndrome develop? The incubation period is usually 1-2 weeks after the primary infection.
- Is it possible to completely cure the disease? Yes, with timely diagnosis and adequate treatment, full recovery is possible.
- What tests are needed to confirm the diagnosis? Ultrasound/CT of the neck, blood culture, PCR for F. necrophorum are required.
- How long does the treatment last? Antibacterial therapy continues for at least 4 weeks.
- Can the disease recur? Recurrences are rare, occurring in less than 5% cases.
Advice from Dr. Oleg Korzhikov
Many patients ask about disease prevention. I recommend paying close attention to any long-term throat and neck infections and consulting a doctor in a timely manner. A common question is whether it is possible to play sports during treatment. This disease requires strict bed rest until the condition stabilizes. Many are concerned about nutrition - you should stick to a gentle diet, excluding irritating foods.
